Lebenthal Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Lebenthal Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$3.58M	Sell	30,671 -2,282	-7%	-$324K	0.44%	64
2016 Q1	$4.59M	Buy	32,953 +158	+0.5%	+$23.2K	0.8%	23
2015 Q4	$6.25M	Sell	32,795 -5,283	-14%	-$923K	1.47%	4
2015 Q3	$5.96M	Buy	38,078 +80	+0.2%	+$14.6K	1.37%	3
2015 Q2	$6.87M	Sell	37,998 -44	-0.1%	-$7.59K	1.4%	2
2015 Q1	$6.59M	Buy	38,042 +330	+0.9%	+$59.7K	1.55%	3
2014 Q4	$6.98M	Buy	+37,712	New	+$6.99M	3.08%	2

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lebenthal Holdings's ALXN Position: Q2 2016 in Review

Lebenthal Holdings reduced its Alexion Pharmaceuticals (ALXN) stake by 6.9% in Q2 2016, selling an estimated $324K and leaving 30,671 shares worth $3.58M. The position accounts for 0.44% of the portfolio, ranked #64.

Lebenthal Holdings first reported a position in ALXN in Q4 2014 and has held it in 7 quarters since. The position peaked at $6.98M in Q4 2014. 533 funds tracked by Wall St. Rank hold ALXN as of Q2 2016.

Lebenthal Holdings held 30,671 shares of Alexion Pharmaceuticals worth $3.58M as of Q2 2016.
Lebenthal Holdings sold 2,282 Alexion Pharmaceuticals shares in Q2 2016, an estimated $324K.
Alexion Pharmaceuticals made up 0.44% of Lebenthal Holdings's portfolio in Q2 2016, its #64 holding.
Lebenthal Holdings first reported a position in Alexion Pharmaceuticals in Q4 2014 and has held it in 7 quarters since.
Lebenthal Holdings's Alexion Pharmaceuticals position peaked at $6.98M in Q4 2014.
533 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.